LIXIANG EDUCATION HOLDIN-ADR (LXEH)

US53934A1236 - ADR

0.4761  +0.02 (+4.64%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to LXEH. LXEH was compared to 65 industry peers in the Diversified Consumer Services industry. While LXEH seems to be doing ok healthwise, there are quite some concerns on its profitability. LXEH is quite expensive at the moment. It does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year LXEH has reported negative net income.
In the past year LXEH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: LXEH reported negative net income in multiple years.
LXEH had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

LXEH has a Return On Assets (-1.28%) which is comparable to the rest of the industry.
LXEH has a Return On Equity (-3.08%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -1.28%
ROE -3.08%
ROIC N/A
ROA(3y)-14.13%
ROA(5y)-3.31%
ROE(3y)-66.21%
ROE(5y)-29.79%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LXEH has a worse Gross Margin (16.06%) than 84.38% of its industry peers.
LXEH's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for LXEH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-37.23%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

LXEH does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LXEH remains at a similar level compared to 1 year ago.
The debt/assets ratio for LXEH has been reduced compared to a year ago.

2.2 Solvency

LXEH has an Altman-Z score of 0.24. This is a bad value and indicates that LXEH is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of LXEH (0.24) is worse than 62.50% of its industry peers.
LXEH has a debt to FCF ratio of 1.84. This is a very positive value and a sign of high solvency as it would only need 1.84 years to pay back of all of its debts.
LXEH has a Debt to FCF ratio of 1.84. This is amongst the best in the industry. LXEH outperforms 85.94% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that LXEH is not too dependend on debt financing.
LXEH has a Debt to Equity ratio (0.27) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF 1.84
Altman-Z 0.24
ROIC/WACCN/A
WACC5.51%

2.3 Liquidity

LXEH has a Current Ratio of 2.46. This indicates that LXEH is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.46, LXEH is in the better half of the industry, outperforming 71.88% of the companies in the same industry.
A Quick Ratio of 2.45 indicates that LXEH has no problem at all paying its short term obligations.
LXEH's Quick ratio of 2.45 is fine compared to the rest of the industry. LXEH outperforms 73.44% of its industry peers.
Industry RankSector Rank
Current Ratio 2.46
Quick Ratio 2.45

4

3. Growth

3.1 Past

LXEH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 96.71%, which is quite impressive.
LXEH shows a strong growth in Revenue. In the last year, the Revenue has grown by 43.02%.
Measured over the past years, LXEH shows a very strong growth in Revenue. The Revenue has been growing by 54.27% on average per year.
EPS 1Y (TTM)96.71%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q98.94%
Revenue 1Y (TTM)43.02%
Revenue growth 3Y54.27%
Revenue growth 5YN/A
Revenue growth Q2Q131.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LXEH. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, LXEH is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.58
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for LXEH!.
Industry RankSector Rank
Dividend Yield N/A

LIXIANG EDUCATION HOLDIN-ADR

NASDAQ:LXEH (5/3/2024, 7:04:32 PM)

0.4761

+0.02 (+4.64%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.17M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.28%
ROE -3.08%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 16.06%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.46
Quick Ratio 2.45
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)96.71%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)43.02%
Revenue growth 3Y54.27%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y